本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

NovoCure Limited

12.28
-0.0500-0.41%
成交量:22.13万
成交额:271.80万
市值:13.73亿
市盈率:-7.87
高:12.44
开:12.26
低:12.12
收:12.33
52周最高:34.13
52周最低:10.87
股本:1.12亿
流通股本:9,414.79万
量比:0.61
换手率:0.24%
股息:- -
股息率:- -
每股收益(TTM):-1.5604
每股收益(LYR):-1.5638
净资产收益率:-48.07%
总资产收益率:-8.64%
市净率:3.93
市盈率(LYR):-7.85

数据加载中...

2024/10/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/15

重要事件披露

Form 8-K - Current report
2024/09/03

重要事件披露

Form 8-K - Current report
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/25

重要事件披露

Form 8-K - Current report
2024/07/10

SEC问询函

Form CORRESP - Correspondence
2024/07/10

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report